Annual International Conference on ADHD Hosted by CHADD, ADDA and ACO Provides Trusted Information, Guidance and Support to the ADHD Community
LANHAM, Md., Nov. 07, 2024 (GLOBE NEWSWIRE) — The leading experts in attention-deficit/hyperactivity disorder (ADHD) will convene to share trusted information about the latest research, treatment options, and practical guidance with the ADHD community at the Annual International Conference on ADHD 2024, November 14 through 16, in Anaheim, California. This premier event is hosted by…
Read MoreWork Advice: How far should I go to accommodate a neurodivergent colleague?
It’s important to start by asking them what would help them succeed. The results may surprise you.
Read MoreIs ADHD Really a ‘Superpower’?
In the past three weeks, at least four people have asked me if I’ve listened to the song “ADHD” by Paris Hilton. The single from her new album is a heavily auto-tuned account of her struggles with the disorder she was diagnosed with as an adult, including racing thoughts, inability to sleep, and feeling like…
Read More“I Have Adult ADHD. My Wife Suffers From It.”
Key points: The effects of ADHD on adults with the diagnosis are well documented. The effects of a partner’s ADHD on the non-ADHD partner or spouse are less known. A recent study showed the difficulties reported by non-ADHD wives living with husbands with ADHD. Psychoeducation has been advised for ADHD-affected couples but more programs are…
Read MoreEight reasons why ADHD diagnoses are increasing
For a long time it was assumed that somewhere between 5 and 6% of children have attention-deficit hyperactivity disorder (ADHD). But the rates, in practice, are often higher.
Read MoreStudy delves into the lives of neurodivergent psychiatrists
Groundbreaking research exploring the experiences of autistic psychiatrists has revealed that psychiatrists who are unaware that they themselves are autistic may fail to recognise the condition in their patients. The study, conducted by researchers from University College Dublin, London South Bank University, Brighton and Sussex Medical School, is the first of its kind to delve…
Read MoreRakesh Jain, MD, MPH discusses once-daily clonidine hydrochloride (ONYDA XR) for ADHD
In this Contemporary Pediatrics video interview, Rakesh Jain, MD, MPH, clinical professor, psychiatry, Texas Tech University School of Medicine, discussed the now-available, FDA-approved clonidine hydrochloride (ONYDA XR; Tris Pharma).
Read MoreHow ADHD Affects Clinical Practice
Godfrey-Harris and Shaw (2023) define Attention Deficit/Hyperactivity Disorder (ADHD) as “a form of neurodivergence, characterized by lifelong differences in attention, impulsivity, and hyperactivity.” While there are considerations for each ADHD subtype, this article will only focus on general presentations as many co-morbidities may occur between the subtypes.
Read MoreAdolescents’ genetic risks tied to psychotic symptoms
In a recent study published in Nature Mental Health, researchers examine the relationships between neuropsychiatric and cognitive polygenic scores (PGSs), attention-related phenotypes, and psychosis spectrum symptoms.
Read MoreViloxazine ER for ADHD Reduces Weight Among Adults With Overweight, Obesity
Relative to placebo, Viloxazine extended-release (viloxazine ER) treatment for attention-deficit hyperactivity disorder (ADHD) is associated with significant weight loss – particularly among adults with overweight and/or obesity at baseline. These study results were presented at Psych Congress 2024, held from October 29 to November 2, 2024 in Boston, Massachusetts.
Read MoreFor some elite athletes, neurodivergence can be a super strength
The hyperfocus on tasks that is common with ADHD and autism is a real asset when it comes to sports.
Read MoreWhen It Comes to ADHD in Women, There’s Still So Much to Learn
For girls and women living with attention-deficit/hyperactivity disorder (ADHD), and the clinicians who treat them, there are still more questions than answers regarding how the condition evolves over the lifespan.
Read More